InvestorsHub Logo
Followers 34
Posts 13819
Boards Moderated 0
Alias Born 12/31/2010

Re: sosjtb post# 7720

Tuesday, 03/26/2019 11:35:35 PM

Tuesday, March 26, 2019 11:35:35 PM

Post# of 42449
Can’t say I don’t like this comment

“and utilization. We also believe we have the opportunity to benefit from various regulatory incentives, such as orphan drug exclusivity, breakthrough therapy designation, fast track designation, priority review and accelerated approval.”

Here’s to incentive